Detailed Information on Publication Record
2021
Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation
RADOCHA, Jakub, Tomas JELINEK, Luděk POUR, Ivan SPICKA, Jiri MINARIK et. al.Basic information
Original name
Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation
Authors
RADOCHA, Jakub (203 Czech Republic, guarantor), Tomas JELINEK (203 Czech Republic), Luděk POUR (203 Czech Republic, belonging to the institution), Ivan SPICKA (203 Czech Republic), Jiri MINARIK (203 Czech Republic), Tereza POPKOVA (203 Czech Republic), Alexandra JUNGOVA (203 Czech Republic), Petr PAVLICEK (203 Czech Republic), Lucie BROŽOVÁ (203 Czech Republic), Martin ŠTORK (203 Czech Republic, belonging to the institution), Frantisek SEDLAK (203 Czech Republic), Petra KRHOVSKA (203 Czech Republic), Vladimir MAISNAR (203 Czech Republic), Adriana HEINDORFER (203 Czech Republic), Michal SYKORA (203 Czech Republic), Marek WROBEL (203 Czech Republic), Peter MIKULA (203 Czech Republic), Petr KESSLER (203 Czech Republic), Jana ULLRYCHOVA (203 Czech Republic) and Roman HAJEK (203 Czech Republic)
Edition
International Journal of Laboratory Hematology, MALDEN, WILEY-BLACKWELL, 2021, 1751-5521
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30205 Hematology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.450
RIV identification code
RIV/00216224:14110/21:00121704
Organization unit
Faculty of Medicine
UT WoS
000607843000001
Keywords in English
Urine immunofixation negativity; intact immunoglobulin multiple myeloma
Tags
International impact, Reviewed
Změněno: 7/12/2021 13:49, Mgr. Tereza Miškechová
Abstract
V originále
The definition of complete disease response (CR) in multiple myeloma (MM) continues to be reevaluated. The last widely accepted model of response assessment was proposed by the International Myeloma Working Group (IMWG) in 2016.1 Urine immunofixation (uIFE), one of the CR parameters, is being frequently omitted from CR evaluation in routine clinical practice. Patients with missing uIFE are then reported as having very good partial response (VGPR).2 It has been recently suggested in retrospective analysis by Lahuerta et al3 that patients with intact immunoglobulin myeloma (IIMM) who lack uIFE examination present with the very same prognosis as the patients with negative uIFE and therefore uIFE might not be necessary for CR definition in such patients.